Ascites Fluid Removal Devices Market to Reach $1.59 Billion by 2036

Got story updates? Submit your updates here. ›

The global ascites fluid removal devices market is projected to grow from $744.6 million in 2026 to approximately $1.59 billion by 2036, representing a CAGR of 7.9%. This growth is fueled by the rising prevalence of liver cirrhosis, heart failure, and various cancers, which lead to excess fluid buildup. Automated paracentesis systems are gaining popularity as they allow patients to manage fluid removal at home, reducing hospital visits.

Why it matters

The shift toward automated and home-based ascites management systems is driven by the push for value-based healthcare, which encourages solutions that improve patient quality of life and reduce costly hospital readmissions. This market growth highlights the need for innovative medical devices that can effectively manage chronic conditions like liver disease and cancer-related fluid buildup.

The details

Automated paracentesis systems hold the leading 52.0% market share, as they eliminate the need for external drainage bags or needles by automatically moving fluid from the abdomen to the bladder. While hospitals remain the primary point of care, there is a growing trend toward specialty clinics and home care as advanced drainage systems allow safer outpatient maintenance. North America leads the market, but Asia-Pacific is the fastest-growing region due to large patient populations and expanding healthcare infrastructure.

• The ascites fluid removal devices market is projected to grow from $744.6 million in 2026 to approximately $935 million by 2029.
• The market valuation is expected to reach $1.22 billion by 2032 and $1.59 billion by 2036.

What’s next

The market faces challenges such as the high cost of advanced implantable and automated devices, which may limit adoption in low-income regions. Furthermore, the risk of complications requires specialized training that remains a barrier in underserved markets.